Most Recent

image: <em>The Scientist</em> at the March for Science in Washington, DC: April 22, 2017

The Scientist at the March for Science in Washington, DC: April 22, 2017

By and | April 23, 2017

Thousands of scientists and science supporters marched from the Washington Monument to the US Capitol this weekend.

0 Comments

image: Marching Into an Uncertain Future

Marching Into an Uncertain Future

By | April 20, 2017

Can professional organizations and societies parlay the groundswell of support culminating in this weekend’s March for Science into more-effective science advocacy?

1 Comment

image: TS Picks: April 20, 2017

TS Picks: April 20, 2017

By | April 20, 2017

March for Science edition

0 Comments

image: Image of the Day: Stop Signals

Image of the Day: Stop Signals

By | April 17, 2017

Transcytosis, suppression of vesicle traffic across cells, helps reduce permeability in the blood-retinal barrier during development.

0 Comments

image: Viral Trigger for Celiac Disease?

Viral Trigger for Celiac Disease?

By | April 6, 2017

A common, seemingly benign human virus can trigger an immune response that leads to celiac disease in a mouse model, researchers show. 

3 Comments

image: Trump Meets with HHS, NIH Brass

Trump Meets with HHS, NIH Brass

By | April 5, 2017

President Donald Trump, HHS Secretary Tom Price, and NIH Director Francis Collins discussed the opioid crisis and retaining young researchers in the biomedical research enterprise, among other things, according to a White House official.

0 Comments

image: Book Excerpt from <em>The Politics of Cancer</em>

Book Excerpt from The Politics of Cancer

By | April 1, 2017

In Chapter 2, “Identifying the Culprits,” author Wendy Whitman Cobb describes how small-government, anti-regulation conservatism can hinder the fight against cancer.

0 Comments

image: Contributors

Contributors

By | April 1, 2017

Meet some of the people featured in the April 2017 issue of The Scientist.

0 Comments

image: Gel Scaffolds for Delivery of Immunotherapies

Gel Scaffolds for Delivery of Immunotherapies

By | April 1, 2017

Using biocompatible polymers to carry cancer immune therapies directly to the tumor

0 Comments

image: How Will Cancer Research Fare Under Trump?

How Will Cancer Research Fare Under Trump?

By | April 1, 2017

The new administration has not yet made its intentions clear.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS